Reply: Inspiris durability in the pulmonic position: Age may matter, but more than for other valves?

We appreciate the comments by Shikata and Miyaji1 regarding our retrospective, single-center experience with the Inspiris Resilia valve (Edwards Lifesciences) in the pulmonic position in pediatric and adult cohorts with congenital heart disease.2 In our propensity score-matched cohort, we demonstrated significantly lower 2-year freedom from valve failure —driven mostly by pulmonary regurgitation—among patients who received an Inspiris valve compared with other prostheses. Additionally, implantation of the Inspiris valve in the native right ventricular outflow tract was associated with earlier development of at least moderate pulmonary regurgitat ion than use within a conduit.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Letter to the Editor Source Type: research